InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...

Investing in stocks inevitably means buying into some companies that perform poorly. Long term InMode Ltd. (NASDAQ:INMD) shareholders know that all too well, since the share price is down considerably ...

The firm is scheduled to report its financial performance for Q4 and fiscal 2025 ahead of the market open on Tuesday, Feb. 10 ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...